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BACKGROUND
Chronic diseases are currently responsible for more deaths than all other causes of death combined.1 The increased prevalence of diseases such as Chronic Kidney Disease (CKD), Diabetes Mellitus (DM) and cardiovascular 
disease (CVD) and the high mortality associated with these diseases is increasingly being recognised as a global public health problem.2-4 This global burden of disease is fuelled by factors such as the increased 
prevalence of obesity, unhealthy life-style choices, and the aging population.1,5,6 These chronic diseases are highly prevalent in Australia and there is a well-established association between these three diseases. In view 
of this high association between these chronic diseases, many patients have a number of co-morbidities and suffer from more than one of these diseases.7-9 Historically, the management of each of these diseases has 
been in isolation or in disease silos with care delivered by medical practitioners and focusing on an individual chronic disease.10,11 As the demand on health care services increases, novel approaches in chronic disease 
management are being explored. In 2014 an Integrated Chronic Disease Nurse Practitioner (ICDNP) model commenced to provide streamlined care, improve access through a coordinated approach for patients with at 
least two of these three chronic diseases, and to improve the patient journey and quality of life.
AIM
To examine the perceptions of stakeholders following the introduction of the ICDNP clinic. 
METHODS
Using a qualitative descriptive design, 14 patient interviews and 3 focus groups with staff (medical, allied 
health, nursing and administrative) were conducted. Data was analysed for themes. 
RESULTS
Overall patients described the benefits of attending the clinic (see figure 1) were due to: 
  1) the good communication and interaction with the nurse practitioners and 
  2) how this contributed to building trust and enabling them to have a better understanding of their chronic diseases. 
Staff recognised the positive impact that the ICDNP clinic had on the patient’s navigation of the healthcare system, reducing the need for multiple clinic appointments, and how the clinic contributes to improving chronic 
disease self-management. 
Figure 1: Themes and Data Excerpts
CONCLUSION
The ICDNP model of care has shown a high level of patient satisfaction with regard to the their journey of chronic disease self-management. Importantly healthcare 
professionals are supportive and engaged with the clinic due to improved communication and collaboration across multiple specialties and relevant team members.
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The specialist only just tell 
it what is in the blood test 
and everything and...they not 
going in that deep talk. Yeah 
and [the NP] is the deep talk.. 
if I can’t, if I can’t understand 
I ask it - what’s that mean, 
what’s this...?
It’s given me a lot better knowledge 
and yeah boosted my confidence really 
well to deal with it, because I feel more 
connected with health service so to 
speak, because of it, you know what I 
mean, rather than just being a patient 
doctor relationship, it’s more involved 
[Patient]
...the way the clinics set 
up and I think it’s quite 
revolutionary around how 
they’ve done it and I think it 
could be rolled out statewide 
and I...I think the patient 
outcomes would be greatly 
improved
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